| Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687) |
|---|
| 09/10/2004 | WO2004076418A1 Ligands that modulate lxr-type receptors |
| 09/10/2004 | WO2004076413A2 Phenyl- and pyridylpiperidine-derivatives as modulators of glucose metabolism |
| 09/10/2004 | WO2004076412A2 Aminoheteroaryl compounds as protein kinase inhibitors |
| 09/10/2004 | WO2004076411A2 Aminocyclopentyl fused heterotricylicamide modulators of chemokine receptor activity |
| 09/10/2004 | WO2004076407A2 Pyrrolidine derivatives as oxytocin antagonists |
| 09/10/2004 | WO2004075895A1 Ocular hypotensive agent |
| 09/10/2004 | WO2004075891A1 1,3-substituted cycloalkyl derivatives containing acidic, mainly heterocyclic groups, corresponding production method and use of said derivatives as medicaments |
| 09/10/2004 | WO2004075815A2 Diarylcycloalkyl derivatives, method for their production and their use as medicaments |
| 09/10/2004 | WO2004060362A3 COMPOSITIONS AND METHODS FOR INHIBITING TGF-β |
| 09/10/2004 | WO2004056727A8 Process of making chalcone derivatives |
| 09/10/2004 | WO2004022523A3 1, 3-diamino-2-hydroxypropane prodrug derivatives |
| 09/10/2004 | CA2517386A1 4-(3- (2-phenyl-oxazol-4-ylmethoxy)-cyclohexyloxy)-butane acid derivatives and related compounds as ppar modulators for treating diabetes of type 2 and atherosclerosis |
| 09/10/2004 | CA2517381A1 3-(2-phenyl-oxazol-4-yl methoxy) cyclohexylmethoxy acetic acid derivatives and related compounds used as ppar modulators for treating type 2 diabetes and arteriosclerosis |
| 09/10/2004 | CA2517307A1 1,3-substituted cycloalkyl derivatives containing acidic, mainly heterocyclic groups, corresponding production method and use of said derivatives as medicaments |
| 09/10/2004 | CA2517256A1 Aminoheteroaryl compounds as protein kinase inhibitors |
| 09/10/2004 | CA2516705A1 Aminocyclopentyl fused heterotricylicamide modulators of chemokine receptor activity |
| 09/10/2004 | CA2516657A1 Cycloalkyl derivatives comprising bioisosteric carboxylic acid groups, method for the production thereof, and use thereof as a medicament |
| 09/10/2004 | CA2516620A1 3-methyl-2- (3- (2-phenyl-oxazol-4-ylmethoxy)-cyclohexanecarbonyl-amino butyric acid derivatives and related compounds as ppar modulators for the treatment of type 2 diabetes and atherosclerosis |
| 09/10/2004 | CA2516573A1 Diarylcycloalkyl derivatives, method for their production and their use as medicaments |
| 09/10/2004 | CA2516407A1 Heteroarylcarbamoylbenzene derivatives |
| 09/10/2004 | CA2515963A1 Phenyl- and pyridylpiperidine-derivatives as modulators of glucose metabolism |
| 09/10/2004 | CA2512886A1 Ligands that modulate lxr-type receptors |
| 09/09/2004 | US20040176610 Indolone oxazolidinones and derivatives thereof |
| 09/09/2004 | US20040176609 Compounds used as bactericides for treatment of infections |
| 09/09/2004 | US20040176605 Compounds as antumor agents or immunosuppressants |
| 09/09/2004 | US20040176595 Glucocorticoid receptor modulators |
| 09/09/2004 | US20040176593 Cyclic diamine compounds used as drugs and chemical intermediates |
| 09/09/2004 | US20040176433 treatment of tumor necrosis factor mediated disorders; asthma; inflammatory bowel disease; arthritis |
| 09/09/2004 | US20040176428 treatment of Type 2 diabetes mellitus, obesity and lipid disorders; coadministration with HMG CoA reductase inhibitors |
| 09/09/2004 | US20040176422 Heteroarylheteroalkylamine derivatives and their use as inhibitors of nitric oxide synthase |
| 09/09/2004 | US20040176418 protease activated receptor (PAR) antagonists will be useful in the treatment of thrombotic, inflammatory, atherosclerotic and fibroproliferative disorders |
| 09/09/2004 | US20040176389 Piperazine oxime dervatives having nk-1 receptor antagonistic activity |
| 09/09/2004 | US20040176388 example compound: cis-1-[(2-chloro-3-trifluoromethylphenyl)acetyl]-6-(3,4,5-trimethylpiperazin-1-yl)indole; treatment of CNS and other disorders |
| 09/09/2004 | US20040176385 treating cancer by inhibiting phosphotidylinositol 3-kinase; in combination with other known agents to modulate cellular proliferation |
| 09/09/2004 | US20040176379 agonist effect from one or more of a somatostatin subtype receptor; diabetes mellitus, hyperlipidemia, insulin insensitivity, Syndrome X; inhibiting the proliferation of helicobacter pylori |
| 09/09/2004 | US20040176377 inhibitors of glycogen synthase kinase-3 beta; treatment of diabetes or neurodegenerative diseases such as Alzheimer's disease; 6-(2-butylamino-pyrimidin-4-yl)-3-oxo-2,3-dihydro-pyridazine-4-carboxylic acid (3-pyridin-3-yl-propyl)-amide, as example |
| 09/09/2004 | US20040176374 Arylsulfonamides as antiviral agents |
| 09/09/2004 | US20040176358 Compositions and methods relating to novel compounds and targets thereof |
| 09/09/2004 | US20040176325 P38 MAP kinase inhibitors comprising indazole derivatives; antiinflammatory and antiproliferative agents; autoimmune, bone, and neurodegenerative disorders; viricides, infections |
| 09/09/2004 | DE10306502A1 Substituierte 3-(Benzoylureido)-thiophenderivate, Verfahren zu deren Herstellung und deren Verwendung Substituted 3- (Benzoylureido) -thiophenderivate, processes for their preparation and their use |
| 09/09/2004 | DE10306250A1 Substituierte N-Arylheterozyklen, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel Substituted N-Arylheterozyklen, processes for their preparation and their use as medicaments |
| 09/08/2004 | EP1454902A1 N- (substituted five-membered di-or triaza diunsaturated ring)carbonyl guanidine derivateives for the treatment of ischemia |
| 09/08/2004 | EP1453823A1 2-guanidino-4-heterocyclylquinazolines |
| 09/08/2004 | EP1453815A1 Metabotropic glutamate receptor-5 modulators |
| 09/08/2004 | EP1453806A1 Aminotetralin derivatives as muscarinic receptor antagonist |
| 09/08/2004 | EP1453805A1 4-piperidinyl alkylamine derivatives as muscarinic receptor antagonists |
| 09/08/2004 | EP1453789A2 N,n'-substituted-1,3-diamino-2-hydroxypropane derivatives |
| 09/08/2004 | EP1453515A2 Method to treat cystic fibrosis |
| 09/08/2004 | EP1453513A1 Use of fpt inhibitors and at least two antineoplastic agents in the treatment of cancer |
| 09/08/2004 | EP1453502A2 Pharmaceutical formulations comprising indolinone derivatives |
| 09/08/2004 | EP1453501A1 N- aryl-n'-arylcycloalkyl-urea derivatives as mch antagonists for the treatment of obesity |
| 09/08/2004 | EP1047678B1 1-substituted-1-aminomethyl-cycloalkane derivatives (=gabapentin analogues), their preparation and their use in the treatment of neurological disorders |
| 09/08/2004 | EP0824524B1 Alpha-substituted pyrimidine-thioalkyl and alkylether compounds as inhibitors of viral reverse transcriptase |
| 09/08/2004 | EP0729455B1 Indole-derived azylpiperazines as ligands for 5ht1-like receptors 5ht1b and 5ht1d |
| 09/08/2004 | EP0623126B1 Imidazole derivatives and their use as cytokine inhibitors |
| 09/08/2004 | CN1527830A Ether derivatives useful as inhibitors of PDE4 isozymes |
| 09/08/2004 | CN1527827A Therapeutic heterocyclic compounds |
| 09/08/2004 | CN1527819A Novel heterocyclic compound and medicinal use thereof |
| 09/08/2004 | CN1527710A Substituted pyrazinones, pyridines and pyrimidines as corticotropin releasing factor ligands |
| 09/08/2004 | CN1527701A Tablets quickly disintegrated in oral cavity |
| 09/08/2004 | CN1165534C Heterocyclyl amino methyloxazolidinones as antibacterials |
| 09/08/2004 | CN1165533C Spiropiperidine derivatives |
| 09/08/2004 | CN1165532C Substituted 3-cyanoquinolines as protein tyrosine kinase inhibitors |
| 09/07/2004 | US6787652 Lowering lipids and serum cholesterol without generating adverse cardiac effects; 4,5-dihydro-3,5-dioxo-1,2,4-triazine derivatives |
| 09/07/2004 | US6787651 Substituted indoles, pharmaceutical compounds containing such indoles and their use as PPAR-γ binding agents |
| 09/07/2004 | US6787561 Benzimidazole compounds |
| 09/07/2004 | US6787556 Benzoic acid derivatives for the treatment of diabetes mellitus |
| 09/07/2004 | US6787555 Such as 4-(4-fluorophenyl)-5-(2-phenylmethylamino)pyrimidin-4-yl)-1-ethoxymethyl -(1,2,3)triazole for inhibition of release of inflammatory interleukins; for treatment of osteoarthritis, rheumatoid arthritis, and congestive heart failure |
| 09/07/2004 | US6787552 PPAR delta activators |
| 09/07/2004 | US6787546 Heterocycle derivatives and drugs |
| 09/07/2004 | US6787543 Preparation of tachykinin antagonists; substituted nitrogen-containing heterocycles |
| 09/07/2004 | US6787542 Aryl phenylheterocyclyl sulfide derivatives and their use as cell adhesion-inhibiting anti-inflammatory and immune-suppressive agents |
| 09/07/2004 | US6787540 Compounds useful as reversible inhibitors of cysteine proteases |
| 09/02/2004 | WO2004074291A1 Triazole compounds useful in therapy |
| 09/02/2004 | WO2004074284A1 Oxazole-derivatives as ppar agonists |
| 09/02/2004 | WO2004074282A1 Antibacterial indolone oxazolidinones, intermediates for their preparation and pharmaceutical compositions containing them |
| 09/02/2004 | WO2004074280A1 Pyridine derivatives as fungicidal compounds |
| 09/02/2004 | WO2004074274A1 Substituted n-aryl nitrogen heterocycles |
| 09/02/2004 | WO2004074272A1 Anthelmintic agents and insecticidal compositions |
| 09/02/2004 | WO2004074270A2 Inhibitors of hepatitis c virus rna-dependent rna polymerase, and compositions and treatments using the same |
| 09/02/2004 | WO2004074263A1 Bicyclic heterocycles, medicaments containing said compounds, use thereof, and method for the production thereof |
| 09/02/2004 | WO2004074262A1 Hiv replication inhibiting pyrimidines and triazines |
| 09/02/2004 | WO2004074261A1 Hiv replication inhibiting pyrimidines and triazines |
| 09/02/2004 | WO2004074257A1 Non-nucleoside reverse transcriptase inhibitors |
| 09/02/2004 | WO2004074218A2 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same |
| 09/02/2004 | WO2004073606A2 Sulfonamide derivatives as ppar modulators |
| 09/02/2004 | WO2004058730A3 Triazole derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase-1 |
| 09/02/2004 | WO2004050036A3 Quinolines and nitrogenated derivatives thereof and their use as antibacterial agents |
| 09/02/2004 | WO2004035569A3 Novel compounds with antibacterial activity |
| 09/02/2004 | WO2004014851A3 Tyrosine kinase inhibitors |
| 09/02/2004 | WO2003099786A3 Aromatic sulfones and their medical use |
| 09/02/2004 | US20040171881 N,N'-substituted-1,3-diamino-2-hydroxypropane derivatives |
| 09/02/2004 | US20040171848 Fluoropyrrolidines as dipeptidyl peptidase inhibitors |
| 09/02/2004 | US20040171842 VIRICIDES; uSING A SECONDARY AMIDE COMPOUNDAIDS |
| 09/02/2004 | US20040171841 Complexes; used for catalyst |
| 09/02/2004 | US20040171835 Tetrahydroquinoline derivative compound and drug containing the compound as active ingredient |
| 09/02/2004 | US20040171798 treatment of diseases regulated by the activation and degranulation of eosinophils, especially asthma, chronic bronchitis, and chronic obstructuive pulmonary disease |
| 09/02/2004 | US20040171654 Sulfur compounds such as 4-tert-Butyl-N-[4-chloro-2-(1-oxy-pyridine-4-carbonyl)-phenyl]-benzenesulfonamide, used as chemokine receptor antagonists, antiinflamatory agents or as immunology modulators |
| 09/02/2004 | US20040171651 Regulating and tailoring expression levels; such as N-[3-(4-chloro-phenyl)-5,5-dimethyl-[1,2,4]oxadiazol-4-yl]-3-ethyl-benzamide |
| 09/02/2004 | US20040171650 Fighting parasitic infections in human and animals; 1,2,4-triazol-3-thioyl derivatives |